{"product_id":"advanced-practice-in-critical-care-9781405185653","title":"Advanced Practice in Critical Care","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAdvanced Practice in Critical Care\u003c\/i\u003e provides experienced critical care nurses with a clear and distinct evidence base for contemporary critical care practice. Central to the book is the application of research and evidence to practice and therefore, case studies and key critical care clinical situations are used throughout to guide the reader through the patient care trajectory.  \u003cp\u003e\u003c\/p\u003e \u003cp\u003e\u003c\/p\u003e \u003cp\u003eEach chapter introduces an initial patient scenario and as the chapter progresses, the patient scenario develops with the theoretical perspectives and application. In this way, it is evident how multi-organ dysfunction develops, impacting upon and influencing other body systems, demonstrating the multi-organ impact that is often experienced by the critically ill patient. In this way, consequences of critical illness such as acute renal failure, haemostatic failure and liver dysfunction are explored. Throughout the text, key research findings and critical care treatment strategies are r\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003ePreface ix\u003c\/p\u003e \u003cp\u003eContributors and acknowledgements xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Challenges in contemporary critical care 1\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSarah McGloin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003eCritical care without walls 1\u003c\/p\u003e \u003cp\u003eAdvanced practice 2\u003c\/p\u003e \u003cp\u003eInterprofessional roles within critical care 5\u003c\/p\u003e \u003cp\u003eConclusion 7\u003c\/p\u003e \u003cp\u003eReferences 7\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 The physiological basis of critical illness 9\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMark Ranson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 9\u003c\/p\u003e \u003cp\u003ePatient scenario 9\u003c\/p\u003e \u003cp\u003eMechanisms of cellular damage 10\u003c\/p\u003e \u003cp\u003eImpact of reduced perfusion on energy production 12\u003c\/p\u003e \u003cp\u003eEvaluation of ischaemia: reperfusion injury 13\u003c\/p\u003e \u003cp\u003eThe inflammatory response and the role of mediators 14\u003c\/p\u003e \u003cp\u003eMechanisms for haemostasis in relation to critical illness 19\u003c\/p\u003e \u003cp\u003eConclusion 25\u003c\/p\u003e \u003cp\u003eReferences 25\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 The patient with haemodynamic compromise leading to renal dysfunction  26\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eTracey Bowden and Anne McLeod\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 26\u003c\/p\u003e \u003cp\u003ePatient scenario 26\u003c\/p\u003e \u003cp\u003eUnderlying physiology and pathophysiology 27\u003c\/p\u003e \u003cp\u003eAssessment and diagnosis 31\u003c\/p\u003e \u003cp\u003eEvidence-based care 35\u003c\/p\u003e \u003cp\u003eOngoing patient scenario 39\u003c\/p\u003e \u003cp\u003eProgressing pathophysiology 40\u003c\/p\u003e \u003cp\u003eOngoing assessment 47\u003c\/p\u003e \u003cp\u003eEvidence-based care 54\u003c\/p\u003e \u003cp\u003eConclusion 65\u003c\/p\u003e \u003cp\u003eReferences 65\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 The septic patient 71\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSarah McGloin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 71\u003c\/p\u003e \u003cp\u003ePatient scenario 71\u003c\/p\u003e \u003cp\u003eUnderlying physiology and pathophysiology 72\u003c\/p\u003e \u003cp\u003eAssessment and diagnosis 76\u003c\/p\u003e \u003cp\u003eEvidence-based care 81\u003c\/p\u003e \u003cp\u003eOngoing patient scenario 83\u003c\/p\u003e \u003cp\u003eProgressing pathophysiology 84\u003c\/p\u003e \u003cp\u003eOngoing assessment 91\u003c\/p\u003e \u003cp\u003eEvidence-based care 91\u003c\/p\u003e \u003cp\u003eConclusion 100\u003c\/p\u003e \u003cp\u003eReferences 101\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 The patient with acute respiratory failure 105\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAnne McLeod\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 105\u003c\/p\u003e \u003cp\u003ePatient scenario 105\u003c\/p\u003e \u003cp\u003eUnderlying physiology and pathophysiology 106\u003c\/p\u003e \u003cp\u003eAssessment and diagnosis 109\u003c\/p\u003e \u003cp\u003eArterial blood gas analysis 114\u003c\/p\u003e \u003cp\u003eEvidence-based care 122\u003c\/p\u003e \u003cp\u003eOngoing patient scenario 127\u003c\/p\u003e \u003cp\u003eProgressing pathophysiology 127\u003c\/p\u003e \u003cp\u003eOngoing assessment 128\u003c\/p\u003e \u003cp\u003eEvidence-based care 136\u003c\/p\u003e \u003cp\u003eConclusion 140\u003c\/p\u003e \u003cp\u003eReferences 140\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 The patient with chronic respiratory failure 143\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eGlenda Esmond and Anne McLeod\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 143\u003c\/p\u003e \u003cp\u003ePatient scenario 144\u003c\/p\u003e \u003cp\u003eUnderlying physiology and pathophysiology 144\u003c\/p\u003e \u003cp\u003eAssessment and diagnosis 145\u003c\/p\u003e \u003cp\u003eEvidence-based care 148\u003c\/p\u003e \u003cp\u003eOngoing patient scenario 152\u003c\/p\u003e \u003cp\u003eWeaning from ventilatory support 153\u003c\/p\u003e \u003cp\u003eOngoing care 157\u003c\/p\u003e \u003cp\u003eConclusion 158\u003c\/p\u003e \u003cp\u003eReferences 158\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 The patient with an intracranial insult 161\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAnne McLeod\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 161\u003c\/p\u003e \u003cp\u003ePatient scenario 161\u003c\/p\u003e \u003cp\u003eUnderlying physiology and pathophysiology 162\u003c\/p\u003e \u003cp\u003eAssessment and diagnosis 167\u003c\/p\u003e \u003cp\u003eEvidence-based care 168\u003c\/p\u003e \u003cp\u003eOngoing patient scenario 172\u003c\/p\u003e \u003cp\u003eProgressing pathophysiology 174\u003c\/p\u003e \u003cp\u003eOngoing assessment 177\u003c\/p\u003e \u003cp\u003eEvidence-based care 180\u003c\/p\u003e \u003cp\u003eConclusion 185\u003c\/p\u003e \u003cp\u003eReferences 185\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 The patient with a traumatic injury 188\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eElaine Cole and Anne McLeod\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 188\u003c\/p\u003e \u003cp\u003ePatient scenario 188\u003c\/p\u003e \u003cp\u003eMechanisms of injury 189\u003c\/p\u003e \u003cp\u003eAssessment and diagnosis 190\u003c\/p\u003e \u003cp\u003ePrimary and secondary surveys 191\u003c\/p\u003e \u003cp\u003eUnderlying physiology and pathophysiology 192\u003c\/p\u003e \u003cp\u003eEvidence-based care 193\u003c\/p\u003e \u003cp\u003eContinuing patient scenario 196\u003c\/p\u003e \u003cp\u003eEvidence-based care 197\u003c\/p\u003e \u003cp\u003eOngoing patient scenario 200\u003c\/p\u003e \u003cp\u003eProgressing pathophysiology 201\u003c\/p\u003e \u003cp\u003eOngoing assessment 203\u003c\/p\u003e \u003cp\u003eEvidence-based care 207\u003c\/p\u003e \u003cp\u003eManagement of his pelvic injury 211\u003c\/p\u003e \u003cp\u003eConclusion 212\u003c\/p\u003e \u003cp\u003eReferences 212\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 The patient with a diabetic emergency 215\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSarah McGloin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 215\u003c\/p\u003e \u003cp\u003ePatient scenario 215\u003c\/p\u003e \u003cp\u003eUnderlying physiology and pathophysiology 216\u003c\/p\u003e \u003cp\u003eUnderlying pathophysiology 217\u003c\/p\u003e \u003cp\u003eAssessment and diagnosis 221\u003c\/p\u003e \u003cp\u003eEvidence-based care 223\u003c\/p\u003e \u003cp\u003eOngoing care 225\u003c\/p\u003e \u003cp\u003eConclusion 226\u003c\/p\u003e \u003cp\u003eReferences 226\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 The long-term patient in intensive care unit 228\u003c\/b\u003e\u003cbr\u003e\u003ci\u003ePhillipa Tredant\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 228\u003c\/p\u003e \u003cp\u003ePatient scenario 228\u003c\/p\u003e \u003cp\u003eImpact of being in the critical care environment 228\u003c\/p\u003e \u003cp\u003ePsychological effects 230\u003c\/p\u003e \u003cp\u003eUnderlying physiology and physiological effects 235\u003c\/p\u003e \u003cp\u003eQuality of life 240\u003c\/p\u003e \u003cp\u003eRehabilitation process 241\u003c\/p\u003e \u003cp\u003eConclusion 245\u003c\/p\u003e \u003cp\u003eReferences 245\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Ethical considerations in critical care 247\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAnne McLeod\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 247\u003c\/p\u003e \u003cp\u003ePatient scenario 247\u003c\/p\u003e \u003cp\u003eAdmission to critical care 247\u003c\/p\u003e \u003cp\u003eWhat are ethics? 248\u003c\/p\u003e \u003cp\u003eBiomedical ethical model 250\u003c\/p\u003e \u003cp\u003eThe role of outreach 252\u003c\/p\u003e \u003cp\u003eOngoing patient scenario 254\u003c\/p\u003e \u003cp\u003eFutile situations 254\u003c\/p\u003e \u003cp\u003eWithdrawal\/withholding of treatment or euthanasia? 254\u003c\/p\u003e \u003cp\u003ePatient autonomy 256\u003c\/p\u003e \u003cp\u003eThe process of withdrawing or withholding treatment 256\u003c\/p\u003e \u003cp\u003eRole of the nurse 257\u003c\/p\u003e \u003cp\u003eCollaborative decision-making 257\u003c\/p\u003e \u003cp\u003eConclusion 258\u003c\/p\u003e \u003cp\u003eReferences 258\u003c\/p\u003e \u003cp\u003eIndex 261\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407917326679,"sku":"9781405185653","price":46.5,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781405185653.jpg?v=1730500951","url":"https:\/\/bookcurl.com\/products\/advanced-practice-in-critical-care-9781405185653","provider":"Book Curl","version":"1.0","type":"link"}